EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Smolen, Josef S; Landewé, Robert B M; Bijlsma, Johannes W J; Burmester, Gerd R; Dougados, Maxime; Kerschbaumer, Andreas; McInnes, Iain B; Sepriano, Alexandre; van Vollenhoven, Ronald F; de Wit, Maarten; Aletaha, Daniel; Aringer, Martin; Askling, John; Balsa, Alejandro; Boers, Maarten; den Broeder, Alfons A; Buch, Maya H; Buttgereit, Frank; Caporali, Roberto; Cardiel, Mario Humberto; De Cock, Diederik; Codreanu, Catalin; Cutolo, Maurizio; Edwards, Christopher John; van Eijk-Hustings, Yvonne; Emery, Paul; Finckh, Axel; Gossec, Laure; Gottenberg, Jacques-Eric; Hetland, Merete Lund; Huizinga, Tom W J; Koloumas, Marios; Li, Zhanguo; Mariette, Xavier; Müller-Ladner, Ulf; Mysler, Eduardo F; da Silva, Jose A P; Poór, Gyula; Pope, Janet E; Rubbert-Roth, Andrea; Ruyssen-Witrand, Adeline; Saag, Kenneth G; Strangfeld, Anja; Takeuchi, Tsutomu; Voshaar, Marieke; Westhovens, René; van der Heijde, Désirée

doi:10.1136/annrheumdis-2019-216655

Scientific article

English

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

ContributorsSmolen, Josef S; Landewé, Robert B M; Bijlsma, Johannes W J; Burmester, Gerd R; Dougados, Maxime; Kerschbaumer, Andreas; McInnes, Iain B; Sepriano, Alexandre; van Vollenhoven, Ronald F; de Wit, Maarten; Aletaha, Daniel; Aringer, Martin; Askling, John; Balsa, Alejandro; Boers, Maarten; den Broeder, Alfons A; Buch, Maya H; Buttgereit, Frank; Caporali, Roberto; Cardiel, Mario Humberto; De Cock, Diederik; Codreanu, Catalin; Cutolo, Maurizio; Edwards, Christopher John; van Eijk-Hustings, Yvonne; Emery, Paul; Finckh, Axel

; Gossec, Laure; Gottenberg, Jacques-Eric; Hetland, Merete Lund; Huizinga, Tom W J; Koloumas, Marios; Li, Zhanguo; Mariette, Xavier; Müller-Ladner, Ulf; Mysler, Eduardo F; da Silva, Jose A P; Poór, Gyula; Pope, Janet E; Rubbert-Roth, Andrea; Ruyssen-Witrand, Adeline; Saag, Kenneth G; Strangfeld, Anja; Takeuchi, Tsutomu; Voshaar, Marieke; Westhovens, René; van der Heijde, Désirée

Published inAnnals of the Rheumatic Diseases, vol. 79, no. 6, p. 685-699

Publication date2020

Abstract

To provide an update of the European League Against Rheumatism (EULAR) rheumatoid arthritis (RA) management recommendations to account for the most recent developments in the field.

Keywords

Antirheumatic Agents/economics/therapeutic use
Arthritis
Rheumatoid/drug therapy
Biological Products/economics/therapeutic use
Consensus
Drug Therapy
Combination
Europe
Humans
Janus Kinase Inhibitors/therapeutic use
Societies
Medical
Synthetic Drugs/economics/therapeutic use
Systematic Reviews as Topic
Tumor Necrosis Factor-alpha/antagonists & inhibitors

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Recherche clinique dans les rhumatismes inflammatoires (1010)

Citation (ISO format)

SMOLEN, Josef S et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. In: Annals of the Rheumatic Diseases, 2020, vol. 79, n° 6, p. 685–699. doi: 10.1136/annrheumdis-2019-216655

Article (Published version)

Identifiers

PID : unige:151663
DOI : 10.1136/annrheumdis-2019-216655
PMID : 31969328

Journal ISSN0003-4967

360views

137downloads

Creation14/10/2020 15:08:00

First validation14/10/2020 15:08:00

Update time03/02/2025 12:53:16

Status update03/02/2025 12:53:16

Last indexation03/02/2025 12:58:52

Archive ouverte UNIGE

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

To provide an update of the European League Against Rheumatism (EULAR) rheumatoid arthritis (RA) management recommendations to account for the most recent developments in the field.

Technical informations